Ipilimumab/nivolumabFacial palsy and pneumonitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1883卷 / 1期

关键词：

D O I：

10.1007/s40278-021-06168-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：213 / 213

相关论文

共 50 条

[1] Ipilimumab/nivolumabFacial nerve palsy
Reactions Weekly, 2024, 2005 (1) : 465 - 465
[2] Ipilimumab/nivolumabDiffuse pneumonitis: case report
Reactions Weekly, 2020, 1813 (1) : 136 - 136
[3] Ipilimumab/nivolumabHypersensitivity pneumonitis: case report
Reactions Weekly, 2020, 1787 (1) : 304 - 304
[4] Ipilimumab/nivolumabAutoimmune pneumonitis: case report
Reactions Weekly, 2021, 1836 (1) : 432 - 432
[5] Ipilimumab/nivolumabSevere pneumonitis: case report
Reactions Weekly, 2018, 1712 (1) : 311 - 311
[6] Ipilimumab/nivolumabAutoimmune pneumonitis: case report
Reactions Weekly, 2023, 1950 (1) : 229 - 229
[7] Ipilimumab/nivolumabAcute pneumonitis : case report
Reactions Weekly, 2022, 1895 (1) : 228 - 228
[8] Atezolizumab/ipilimumab/nivolumabFacial palsy and other immune-related adverse events: 5 case reports
Reactions Weekly, 2019, 1749 (1) : 77 - 77
[9] Ipilimumab/nivolumabTakotsubo cardiomyopathy and pneumonitis: case report
Reactions Weekly, 2022, 1932 (1) : 338 - 338
[10] Ipilimumab/nivolumabHepatitis, pneumonitis and rash: case report
Reactions Weekly, 2024, 2036 (1) : 230 - 230

← 1 2 3 4 5 →